Enter First, Gather Evidence Later: Dexcom Becomes First Participant in FDA Digital Health Evidence Pilot
The FDA is allowing Dexcom’s glucose health program to collect real-world data in specific healthcare payment settings, in an attempt to connect patient use, reimbursement, and premarket review into a single evidence chain; however, selection for the pilot does not mean the product’s effectiveness has been recognized.